Radiopharm Theranostics Ltd (RADX) Liabilities and Shareholders Equity (2024 - 2025)
Radiopharm Theranostics (RADX) posted quarterly Liabilities and Shareholders Equity of $553858.6 for Q2 2025, up 16.67% year-over-year from $474737.2 in Q2 2024, and up 16.67% quarter-over-quarter from $474737.2 in Q2 2024.
Radiopharm Theranostics Ltd (RADX) Liabilities and Shareholders Equity (2024 - 2025) Analysis & Trends
Radiopharm Theranostics (RADX) has reported Liabilities and Shareholders Equity for 2 consecutive years, with $553858.6 the latest figure, recorded in Q2 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 553,858.65 |
| Jun 30, 2024 | 474,737.15 |